Verona Pharma Plc Overview
Verona Pharma Plc Target Price
Analysts' 12-month price predictions for VRNA.
Share Price
$81.2
Average Target Price
$79.33
2.3% downside
2.3% downside3 analysts in the last 4 months
High: $83 | Low: $75
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-21 | Cantor Fitzgerald | $80 | 1.5% downside |  |
| 2025-02-28 | Roth Capital | $83 |  2.2% upside | |
| 2025-02-28 | H.C. Wainwright | $75 | 7.6% downside | |
| 2025-01-10 | Roth CapitalBoobalan Pachaiyappan | $68 | 16.3% downside | |
| 2025-01-08 | Wells FargoTiago Fauth | $74 | 8.9% downside | |
| 2024-11-05 | H.C. WainwrightRaghuram Selvaraju | $42 | 48.3% downside | |
| 2024-07-22 | Canaccord GenuityEdward Nash | $37 | 54.4% downside | |
| 2024-06-27 | H.C. WainwrightRaghuram Selvaraju | $36 | 55.7% downside | |
| 2024-05-28 | JefferiesAndrew Tsai | $38 | 53.2% downside | |
| 2024-04-16 | Piper SandlerYasmeen Rahimi | $36 | 55.7% downside | |
| 2022-12-21 | H.C. Wainwright | $32 | 60.6% downside | |
| 2022-12-20 | WedbushAndreas Argyrides | $30 | 63.1% downside | |
| 2022-12-20 | Truist Financial | $28 | 65.5% downside | |
| 2022-12-20 | BTIG | $26 | 68% downside | |
| 2022-08-30 | Canaccord GenuityEdward Nash Nash | $27 | 66.7% downside | |
| 2022-08-30 | WedbushLiana Moussatos Moussatos | $23 | 71.7% downside | |
| 2022-08-30 | H.C. WainwrightRaghuram Selvaraju Selvaraju | $30 | 63.1% downside | |